The Eurocine L3 adjuvants with subunit influenza antigens induce protective immunity in mice after intranasal vaccination (Q64130191)

1

0 references

Mona Hedenskog

2

0 references

Denise Alves

3

0 references

Mia Brytting

4

0 references

Ulf Schröder

5

0 references

Annika Linde

6

0 references

Ake Lundkvist

A global pandemic influenza vaccine action plan.

7

0 references

language of work or name

English

0 references

publication date

7 September 2010

0 references

published in

Vaccine

0 references

volume

28

0 references

issue

39

0 references

page(s)

6491-7

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.001

7 January 2021

Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.001

7 January 2021

Cross-protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.001

7 January 2021

Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.001

7 January 2021

Induction of secretory immunity and memory at mucosal surfaces

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.001

7 January 2021

Novel generations of influenza vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.001

7 January 2021

Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.001

7 January 2021

A novel DNA adjuvant, N3, enhances mucosal and systemic immune responses induced by HIV-1 DNA and peptide immunizations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.001

7 January 2021

Nasal and parenteral immunizations with diphtheria toxoid using monoglyceride/fatty acid lipid suspensions as adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.001

7 January 2021

Transient facial nerve paralysis (Bell's palsy) following intranasal delivery of a genetically detoxified mutant of Escherichia coli heat labile toxin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.001

7 January 2021

The global agenda on influenza surveillance and control

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.001

7 January 2021

Immunogenicity and protective efficacy of a formalin-inactivated rotavirus vaccine combined with lipid adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.001

7 January 2021

Influenza virus CTL epitopes, remarkably conserved and remarkably variable.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.001

7 January 2021

Detection of Epstein-Barr virus, but not human herpesvirus 8, DNA in cervical secretions from Swedish women by real-time polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.001

7 January 2021

Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.001

7 January 2021

Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.001

7 January 2021

Development of immune response that protects mice from viral pneumonitis after a single intranasal immunization with influenza A virus and nanoemulsion.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.001

7 January 2021

Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.001

7 January 2021

A new intranasal influenza vaccine based on a novel polycationic lipid--ceramide carbamoyl-spermine (CCS) I. Immunogenicity and efficacy studies in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.001

7 January 2021

Intranasal administration of a synthetic peptide vaccine encapsulated in liposome together with an anti-CD40 antibody induces protective immunity against influenza A virus in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.001

7 January 2021

Protection against influenza virus infection in polymeric Ig receptor knockout mice immunized intranasally with adjuvant-combined vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.001

7 January 2021

Let's go mucosal: communication on slippery ground

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.001

7 January 2021

Oral spray immunization may be an alternative to intranasal vaccine delivery to induce systemic antibodies but not nasal mucosal or cellular immunity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.001

7 January 2021

Chitosan as a novel nasal delivery system for vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.001

7 January 2021

Carbohydrate biopolymers enhance antibody responses to mucosally delivered vaccine antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.001

7 January 2021

Nasal immunization with subunit proteosome influenza vaccines induces serum HAI, mucosal IgA and protection against influenza challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.001

7 January 2021

The adjuvants MF59 and LT-K63 enhance the mucosal and systemic immunogenicity of subunit influenza vaccine administered intranasally in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.001

7 January 2021

Safety and immunogenicity of adjuvanted and unadjuvanted subunit influenza vaccines administered intranasally to healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.001

7 January 2021

Confronting the avian influenza threat: vaccine development for a potential pandemic.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.001

7 January 2021